Novel Compounds as 5‑HT2A Agonists for Treating Mental Illness or CNS Disorders

  • ACS Med Chem Lett. 2025 Aug 8;16(9):1711-1712. doi: 10.1021/acsmedchemlett.5c00460.
Ram W Sabnis  1
Affiliations
  • 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
PMID: 40959240 DOI: 10.1021/acsmedchemlett.5c00460
Abstract

Provided herein are novel compounds as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating mental illness or CNS disorders, and processes for preparing such compounds.

Products